Continuous intrathecal baclofen therapy in children with cerebral palsy - When does improvement emerge?

Acta Paediatrica, International Journal of Paediatrics

Volumn 99, Issue 11, 2010, Pages 1661-1665

  Ramstad, K ^a,c   Jahnsen, R ^a   Lofterod, B ^a   Skjeldal, O H ^b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b INNLANDET HOSPITAL TRUST   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Cerebral palsy; Child; Therapy

Indexed keywords

BACLOFEN;

AROUSAL; ARTICLE; CEREBRAL PALSY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; HUMAN; PAIN; PATIENT MOBILITY; PRIORITY JOURNAL; SLEEP; SOCIAL INTERACTION; SPASTICITY;

ADOLESCENT; BACLOFEN; CEREBRAL PALSY; CHILD; CHILD, PRESCHOOL; DISABILITY EVALUATION; DISABLED CHILDREN; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFUSION PUMPS, IMPLANTABLE; MALE; MOTOR ACTIVITY; MUSCLE RELAXANTS, CENTRAL; MUSCLE SPASTICITY; PAIN MEASUREMENT; SLEEP INITIATION AND MAINTENANCE DISORDERS; TIME FACTORS; TREATMENT OUTCOME;

EID: 78649736843     PISSN: 08035253     EISSN: 16512227     Source Type: Journal    
DOI: 10.1111/j.1651-2227.2009.01596.x     Document Type: Article

References (26)

1. Brashear A, Lambeth K. Spasticity. Curr Treat Options Neurol 2009; 11: 153-61.
2. Albright AL, Gilmartin R, Swift D, Krach LE, Ivanhoe CB, McLaughlin JF. Long-term intrathecal baclofen therapy for severe spasticity of cerebral origin. J Neurosurg 2003; 98: 291-5.
3. Campbell WM, Ferrel A, McLaughlin JF, Grant GA, Loeser JD, Graubert C, et al. Long-term safety and efficacy of continuous intrathecal baclofen. Dev Med Child Neurol 2002; 44: 660-5.
4. Gilmartin R, Bruce D, Storrs BB, Abbott R, Krach L, Ward J, et al. Intrathecal baclofen for management of spastic cerebral palsy: Multicenter trial. J Child Neurol 2000; 15: 71-7.
5. Hoving MA, van Raak EP, Spincemaille GH, Palmans LJ, Becher JG, Vles JS, et al. Efficacy of intrathecal baclofen therapy in children with intractable spastic cerebral palsy: A randomised controlled trial. Eur J Paediatr Neurol 2009; 13: 240-246.
6. Penn RD, Savoy SM, Corcos D, Latash M, Gottlieb G, Parke B, et al. Intrathecal baclofen for severe spinal spasticity. N Engl J Med 1989; 320: 1517-21. (Pubitemid 19145803)
7. Brennan PM, Whittle IR. Intrathecal baclofen therapy for neurological disorders: A sound knowledge base but many challenges remain. Br J Neurosurg 2008; 22: 508-19.
8. Brochard S, Remy-Neris O, Filipetti P, Bussel B. Intrathecal baclofen infusion for ambulant children with cerebral palsy. Pediatr Neurol 2009; 40: 265-70.
9. Motta F, Stignani C, Antonello CE. Effect of intrathecal baclofen on dystonia in children with cerebral palsy and the use of functional scales. J Pediatr Orthop 2008; 28: 213-7.
10. Albright AL, Ferson SS. Intraventricular baclofen for dystonia: Techniques and outcomes. Clinical article. J Neurosurg Pediatr 2009; 3: 11-4.
11. Gooch JL, Oberg WA, Grams B, Ward LA, Walker ML. Care provider assessment of intrathecal baclofen in children. Dev Med Child Neurol 2004; 46: 548-52.
12. Krach LE, Nettleton A, Klempka B. Satisfaction of individuals treated long-term with continuous infusion of intrathecal baclofen by implanted programmable pump. Pediatr Rehabil 2006; 9: 210-8.
13. Hoving MA, van Raak EP, Spincemaille GH, van Kranen- Mastenbroek VH, van KM, Gorter JW, et al. Safety and oneyear efficacy of intrathecal baclofen therapy in children with intractable spastic cerebral palsy. Eur J Paediatr Neurol 2009; 13: 247-256.
14. Hoving MA, Evers SM, Ament AJ, van Raak EP, Vles JS. Intrathecal baclofen therapy in children with intractable spastic cerebral palsy: A cost-effectiveness analysis. Dev Med Child Neurol 2008; 50: 450-5.
15. Kolaski K, Logan LR. A review of the complications of intrathecal baclofen in patients with cerebral palsy. NeuroRehabilitation 2007; 22: 383-95.
16. Anonymous. A report: The definition and classification of cerebral palsy. Dev Med Child Neurol 2007; 49: 8-15.
17. Palisano R, Rosenbaum P, Walter S, Russell D, Wood E, Galuppi B. Development and reliability of a system to classify gross motor function in children with cerebral palsy. Dev Med Child Neurol 1997; 39: 214-23.
18. Haley SM, Coster WJ, Ludlow LH. Pediatric Evaluation of Disability Inventory (PEDI). Development, standardization and administration manual. [Version 1.0]. Boston: Dept of Rehab Med, New England Medical Center Hospital, 2006. [Generic].
19. Bohannon RW, Smith MB. Interrater reliability of a modified Ashworth scale of muscle spasticity. Phys Ther 1987; 67: 206-7.
20. Russell DJ, Avery LM, Rosenbaum PL, Raina PS, Walter SD, Palisano RJ. Improved scaling of the gross motor function measure for children with cerebral palsy: Evidence of reliability and validity. Phys Ther 2000; 80: 873-85.
21. World Health Organization. International classification of functioning, disability and health (ICF). 2008. Available at: Http://www.who.int/entity/ classifications/icf/en/. (accessed November 5, 2009).
22. Cieza A, Stucki G. The international classification of functioning disability and health: Its development process and content validity. Eur J Phys Rehabil Med 2008; 44: 303-13.
23. Arnaud C, White-Koning M, Michelsen SI, Parkes J, Parkinson K, Thyen U, et al. Parent-reported quality of life of children with cerebral palsy in Europe. Pediatrics 2008; 121: 54-64.
24. White-KoningM, Grandjean H, Colver A, Arnaud C. Parent and professional reports of the quality of life of children with cerebral palsy and associated intellectual impairment. Dev Med Child Neurol 2008; 50: 618-24.
25. Dan B, Motta F, Vles JS, Vloeberghs M, Becher JG, Eunson P, et al. Consensus on the appropriate use of intrathecal baclofen (ITB) therapy in paediatric spasticity. Eur J Paediatr Neurol 2009 (in press).
26. Ostensjo S, Bjorbaekmo W, Carlberg EB, Vollestad NK. Assessment of everyday functioning in young children with disabilities: An ICF-based analysis of concepts and content of the Pediatric Evaluation of Disability Inventory (PEDI). Disabil Rehabil 2006; 28: 489-504.